76 related articles for article (PubMed ID: 3066300)
1. Some remarks on application of macrophages in tumor therapy.
Kos FJ
Arch Geschwulstforsch; 1988; 58(6):387-93. PubMed ID: 3066300
[TBL] [Abstract][Full Text] [Related]
2. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.
Fidler IJ; Barnes Z; Fogler WE; Kirsh R; Bugelski P; Poste G
Cancer Res; 1982 Feb; 42(2):496-501. PubMed ID: 7055801
[TBL] [Abstract][Full Text] [Related]
3. Activation of tumoricidal properties in macrophages by lymphokines encapsulated in liposomes.
Fidler IJ; Fogler WE
Lymphokine Res; 1982; 1(3):73-7. PubMed ID: 6765335
[No Abstract] [Full Text] [Related]
4. In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide.
Daemen T; Veninga A; Roerdink FH; Scherphof GL
Cancer Res; 1986 Sep; 46(9):4330-5. PubMed ID: 3731091
[TBL] [Abstract][Full Text] [Related]
5. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
Howard AD; Erickson KL
Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of cancer: experimental approach with activated macrophages proliferating in culture.
Bartholeyns J; Lombard Y; Dumont S; Hartmann D; Chokry M; Giaimis J; Kaufmann S; Poindron P
Cancer Detect Prev; 1988; 12(1-6):413-20. PubMed ID: 3180139
[TBL] [Abstract][Full Text] [Related]
7. Immune control of neoplasia by adoptive transfer of macrophages: potentiality for antigen presentation and gene transfer.
Bartholeyns J; Lopez M
Anticancer Res; 1994; 14(6B):2673-6. PubMed ID: 7872699
[TBL] [Abstract][Full Text] [Related]
8. The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes.
Fidler IJ; Raz A; Fogler WE; Hoyer LC; Poste G
Cancer Res; 1981 Feb; 41(2):495-504. PubMed ID: 7004633
[TBL] [Abstract][Full Text] [Related]
9. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
Fogler WE; Talmadge JE; Fidler IJ
J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
[TBL] [Abstract][Full Text] [Related]
10. Liposome-encapsulated macrophage activation agents and active non-specific immunotherapy of neoplastic disease.
Poste G; Kirsh R
Prog Clin Biol Res; 1982; 102 pt A():309-19. PubMed ID: 7167443
[No Abstract] [Full Text] [Related]
11. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.
Schroit AJ; Fidler IJ
Cancer Res; 1982 Jan; 42(1):161-7. PubMed ID: 7053846
[TBL] [Abstract][Full Text] [Related]
12. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.
Gilbreath MJ; Nacy CA; Hoover DL; Alving CR; Swartz GM; Meltzer MS
J Immunol; 1985 May; 134(5):3420-5. PubMed ID: 3980997
[TBL] [Abstract][Full Text] [Related]
13. Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.
Keller R; Keist R; Van der Meide PH; Groscurth P; Aguet M; Leist TP
J Immunol; 1987 Apr; 138(7):2366-71. PubMed ID: 3104463
[TBL] [Abstract][Full Text] [Related]
14. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
15. Modulation of macrophage function by gamma-irradiation. Acquisition of the primed cell intermediate stage of the macrophage tumoricidal activation pathway.
Lambert LE; Paulnock DM
J Immunol; 1987 Oct; 139(8):2834-41. PubMed ID: 3116096
[TBL] [Abstract][Full Text] [Related]
16. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.
Schorlemmer HU; Bosslet K; Sedlacek HH
Cancer Res; 1983 Sep; 43(9):4148-53. PubMed ID: 6871856
[TBL] [Abstract][Full Text] [Related]
17. Nonselective destruction of murine neoplastic cells by syngeneic tumoricidal macrophages.
Fogler WE; Fidler IJ
Cancer Res; 1985 Jan; 45(1):14-8. PubMed ID: 3855280
[TBL] [Abstract][Full Text] [Related]
18. Activation of macrophage tumoricidal activity by photodynamic treatment in vitro--indirect activation of macrophages by photodynamically killed tumor cells.
Reiter I; Schwamberger G; Krammer B
J Photochem Photobiol B; 1999 Jun; 50(2-3):99-107. PubMed ID: 10515075
[TBL] [Abstract][Full Text] [Related]
19. Role of macrophages in the expression of immune responses.
Kende M
J Am Vet Med Assoc; 1982 Nov; 181(10):1037-42. PubMed ID: 6757210
[TBL] [Abstract][Full Text] [Related]
20. Macrophage activation of lymphoma-bearing mice by liposome-mediated intraperitoneal IL-2 and IL-6 gene therapy.
Wang Q; Cao X; Wang J; Zhang W; Tao Q; Ye T
Chin Med J (Engl); 2000 Mar; 113(3):281-5. PubMed ID: 11775265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
